DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Iwata TN, Ishii C, Ishida S, Ogitani Y, Wada T, Agatsuma T.
A HER2-targeting antibody-drug conjugate, trastuzumab deruxtecan (DS-8201a), enhances antitumor immunity in a mouse model.
Mol Cancer Ther 2018;
17: 1494-503
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.